Found: 60
Select item for more details and to access through your institution.
Development of Breast Cancer in a 21-Year-Old Childhood Wilms' Tumor Survivor With a BRCA1 2634delC Mutation.
- Published in:
- Clinical Breast Cancer, 2011, v. 11, n. 4, p. 268, doi. 10.1016/j.clbc.2010.11.001
- By:
- Publication type:
- Article
Phase I dose escalation study of NMS-1286937, an orally available Polo-Like Kinase 1 inhibitor, in patients with advanced or metastatic solid tumors.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 1, p. 85, doi. 10.1007/s10637-017-0491-7
- By:
- Publication type:
- Article
Integrated Genomic and Epigenomic Analysis of Breast Cancer Brain Metastasis.
- Published in:
- PLoS ONE, 2014, v. 9, n. 1, p. 1, doi. 10.1371/journal.pone.0085448
- By:
- Publication type:
- Article
Chemotherapy induced neutropenia at 1-month mark is a predictor of overall survival in patients receiving TAS-102 for refractory metastatic colorectal cancer: a cohort study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Phase I study of imalumab (BAX69), a fully human recombinant antioxidized macrophage migration inhibitory factor antibody in advanced solid tumours.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1836, doi. 10.1111/bcp.14289
- By:
- Publication type:
- Article
Emerging Therapies and Future Directions in Targeting the Tumor Stroma and Immune System in the Treatment of Pancreatic Adenocarcinoma.
- Published in:
- Cancers, 2018, v. 10, n. 6, p. 193, doi. 10.3390/cancers10060193
- By:
- Publication type:
- Article
Mechanism-based model characterizing bidirectional interaction between PEGylated liposomal CKD-602 (S-CKD602) and monocytes in cancer patients.
- Published in:
- International Journal of Nanomedicine, 2012, v. 7, p. 5555, doi. 10.2147/IJN.S35751
- By:
- Publication type:
- Article
Phase II trial of trimetrexate for patients with advanced gastric carcinoma: an Eastern Cooperative Oncology Group study (E1287).
- Published in:
- 1999
- By:
- Publication type:
- journal article
17-Dimethylaminoethylamino-17- Demethoxygeldanamycin in Patients with Advanced-Stage Solid Tumors and Lymphoma: A Phase I Study.
- Published in:
- Clinical Lymphoma & Myeloma, 2006, v. 6, n. 6, p. 500
- By:
- Publication type:
- Article
Phase I dose-escalation study to examine the safety and tolerability of LY2603618, a checkpoint 1 kinase inhibitor, administered 1 day after pemetrexed 500 mg/m<sup>2</sup> every 21 days in patients with cancer.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 1, p. 136, doi. 10.1007/s10637-012-9815-9
- By:
- Publication type:
- Article
A phase I study of the vitamin D(3) analogue ILX23-7553 administered orally to patients with advanced solid tumors.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Whole genome sequencing reveals potential targets for therapy in patients with refractory KRAS mutated metastatic colorectal cancer.
- Published in:
- BMC Medical Genomics, 2014, v. 7, n. 1, p. 3, doi. 10.1186/1755-8794-7-36
- By:
- Publication type:
- Article
Transfusion-Related Acute Lung Injury following Random Donor Platelet Transfusion: A Report of Two Cases.
- Published in:
- Vox Sanguinis, 1997, v. 73, n. 1, p. 43, doi. 10.1046/j.1423-0410.1997.7310043.x
- By:
- Publication type:
- Article
Updated Efficacy and Toxicity Analysis of Irinotecan and Oxaliplatin (IROX).
- Published in:
- Cancer (0008543X), 2007, v. 110, n. 3, p. 670, doi. 10.1002/cncr.22831
- By:
- Publication type:
- Article
Phase 2 study of vismodegib, a hedgehog inhibitor, combined with gemcitabine and nab-paclitaxel in patients with untreated metastatic pancreatic adenocarcinoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Correction: A phase 2 randomised study of veliparib plus FOLFIRI±bevacizumab versus placebo plus FOLFIRI±bevacizumab in metastatic colorectal cancer.
- Published in:
- 2019
- By:
- Publication type:
- corrected article
A phase 2 randomised study of veliparib plus FOLFIRI±bevacizumab versus placebo plus FOLFIRI±bevacizumab in metastatic colorectal cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A phase 1 dose-escalation study of veliparib with bimonthly FOLFIRI in patients with advanced solid tumours.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Phase 1 trials of PEGylated recombinant human hyaluronidase PH20 in patients with advanced solid tumours.
- Published in:
- British Journal of Cancer, 2018, v. 118, n. 2, p. 153, doi. 10.1038/bjc.2017.327
- By:
- Publication type:
- Article
Phase 1 trials of PEGylated recombinant human hyaluronidase PH20 in patients with advanced solid tumours.
- Published in:
- 2018
- By:
- Publication type:
- corrected article
Phase 1 trials of PEGylated recombinant human hyaluronidase PH20 in patients with advanced solid tumours.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Clinical study of genomic drivers in pancreatic ductal adenocarcinoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Multicohort Retrospective Validation of a Predictive Biomarker for Topoisomerase I Inhibitors.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Phase II study of irinotecan and cetuximab given every 2 weeks as second-line therapy for advanced colorectal cancer.
- Published in:
- 2012
- By:
- Publication type:
- journal article
A Phase I/II Study of Capecitabine Given on a Week on/Week off Schedule Combined With Bevacizumab and Oxaliplatin for Patients With Untreated Advanced Colorectal Cancer.
- Published in:
- Clinical Colorectal Cancer, 2011, v. 10, n. 2, p. 117, doi. 10.1016/j.clcc.2011.03.008
- By:
- Publication type:
- Article
HER2 gene amplification and chromosome 17 copy number do not predict survival of patients with resected pancreatic adenocarcinoma.
- Published in:
- 2008
- By:
- Publication type:
- journal article
A randomized, crossover phase 1 study to assess the effects of formulation (capsule vs tablet) and meal consumption on the bioavailability of dovitinib (TKI258)
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Phase II and pharmacokinetic trial of rebeccamycin analog in advanced biliary cancers.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 65, n. 1, p. 73, doi. 10.1007/s00280-009-1005-x
- By:
- Publication type:
- Article
A phase II study of lapatinib in patients with advanced biliary tree and hepatocellular cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 4, p. 777, doi. 10.1007/s00280-009-0927-7
- By:
- Publication type:
- Article
A phase II study of milataxel: a novel taxane analogue in previously treated patients with advanced colorectal cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 61, n. 3, p. 453, doi. 10.1007/s00280-007-0489-5
- By:
- Publication type:
- Article
Phase I and pharmacokinetic study of the novel redox-active agent, motexafin gadolinium, with concurrent radiation therapy in patients with locally advanced pancreatic or biliary cancers.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Phase I study of weekly (day 1 and 8) docetaxel in combination with capecitabine in patients with advanced solid malignancies.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Pharmacokinetic studies of 9-nitrocamptothecin on intermittent and continuous schedules of administration in patients with solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2004, v. 54, n. 6, p. 487, doi. 10.1007/s00280-004-0835-9
- By:
- Publication type:
- Article
Unusual Relapse of Primary Central Nervous System Lymphoma at Site of Lumbar Puncture.
- Published in:
- 2014
- By:
- Publication type:
- Case Study
A Case Report of Ischemic Stroke in a Patient with Metastatic Gastric Cancer Secondary to Treatment with the Vascular Endothelial Growth Factor Receptor-2 Inhibitor Ramucirumab.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
Hepatoid Carcinoma of the Pancreas: Case Report, Next-Generation Tumor Profiling, and Literature Review.
- Published in:
- Case Reports in Gastroenterology, 2016, v. 10, n. 3, p. 605, doi. 10.1159/000448064
- By:
- Publication type:
- Article
Marantic Endocarditis Associated with Pancreatic Cancer: A Case Series.
- Published in:
- Case Reports in Gastroenterology, 2009, v. 3, n. 1, p. 67, doi. 10.1159/000207195
- By:
- Publication type:
- Article
A phase I/II study of a MUC1 peptide pulsed autologous dendritic cell vaccine as adjuvant therapy in patients with resected pancreatic and biliary tumors.
- Published in:
- Cancer Therapy, 2008, v. 6, n. 2, p. 955
- By:
- Publication type:
- Article
Population Pharmacokinetics of Pegylated Liposomal CKD-602 (S-CKD602) in Patients With Advanced Malignancies.
- Published in:
- Journal of Clinical Pharmacology, 2012, v. 52, n. 2, p. 180, doi. 10.1177/0091270010394851
- By:
- Publication type:
- Article
Biliary Excretion of Imatinib Mesylate and Its Metabolite CGP 74588 in Humans.
- Published in:
- Pharmacotherapy, 2004, v. 24, n. 9, p. 1232, doi. 10.1592/phco.24.13.1232.38095
- By:
- Publication type:
- Article
Recent Advances in the Treatment of Pancreatic Adenocarcinoma: Further Observations.
- Published in:
- Clinical Advances in Hematology & Oncology, 2017, v. 15, p. 15
- By:
- Publication type:
- Article
Development of New Pharmaceutical Therapies for Pancreatic Adenocarcinoma.
- Published in:
- Clinical Advances in Hematology & Oncology, 2017, v. 15, p. 7
- By:
- Publication type:
- Article
Recent Advances in the Treatment of Pancreatic Adenocarcinoma.
- Published in:
- Clinical Advances in Hematology & Oncology, 2017, v. 15, p. 1
- By:
- Publication type:
- Article
Phase Ib Trial of the PI3K Inhibitor Copanlisib Combined with the Allosteric MEK Inhibitor Refametinib in Patients with Advanced Cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Correction to: Phase Ib Trial of the PI3K Inhibitor Copanlisib Combined with the Allosteric MEK Inhibitor Refametinib in Patients with Advanced Cancer.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Second-line treatment in patients with pancreatic ductal adenocarcinoma: A meta-analysis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Phase 2 study of MK-2206, an allosteric inhibitor of AKT, as second-line therapy for advanced gastric and gastroesophageal junction cancer: A SWOG cooperative group trial (S1005).
- Published in:
- 2015
- By:
- Publication type:
- journal article
Dual blockade of epidermal growth factor receptor and insulin-like growth factor receptor-1 signaling in metastatic pancreatic cancer: Phase Ib and randomized phase II trial of gemcitabine, erlotinib, and cixutumumab versus gemcitabine plus erlotinib (SWOG S0727)
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 19, p. 2980, doi. 10.1002/cncr.28744
- By:
- Publication type:
- Article
A Phase 2 Study of PCI-27483, a Factor VIIa Inhibitor in Combination with Gemcitabine for Advanced Pancreatic Cancer.
- Published in:
- Oncology, 2019, v. 96, n. 4, p. 217, doi. 10.1159/000495988
- By:
- Publication type:
- Article
Disseminated Intravascular Coagulation Secondary to Advanced Pancreatic Cancer Treated Successfully with Combination Chemotherapy.
- Published in:
- Oncology, 2014, v. 87, n. 5, p. 266, doi. 10.1159/000365552
- By:
- Publication type:
- Article